Four Reasons Merck & Co., Inc. (MRK)'s R&D Restructuring May Not Save The Drug Giant
12/30/2013 8:22:15 AM
Last Friday, Wall Street Journal reporters Peter Loftus and Jonathan Rockoff broke the story that Merck is planning a dramatic R&D restructuring. The goal is to look externally for more programs, rather than to count on Merck’s legendary research labs to provide the bulk of the pipeline. Four “innovation hubs” will be created, based near Boston, San Francisco, London, and Shanghai.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by